Log In
BCIQ
Print this Print this
 

synNotch T cells

  Manage Alerts
Collapse Summary General Information
Company University of California San Francisco
DescriptionT cells engineered to express a synthetic Notch receptor composed of modular, custom-selected extracellular sensing and intracellular response domains which can be programmed to produce therapeutic agents in the presence of disease-specific molecular cues
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Non-stem cell
Latest Stage of DevelopmentPreclinical
Standard IndicationChronic myelogenous leukemia (CML)
Indication DetailsTreat chronic myelogenous leukemia (CML)
Regulatory Designation
PartnerCell Design Labs Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today